Closed-loop syncHronization vErsuS convenTional Synchronization in sPontaneously Breathing Adult Nonivasive ventilationPatients
Launched by BAŞAKŞEHIR ÇAM & SAKURA CITY HOSPITAL · Apr 5, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new method of helping patients with breathing difficulties, particularly those suffering from conditions like acute respiratory failure or chronic respiratory failure. The researchers want to see if a device that automatically adjusts to the patient’s breathing is better than traditional methods that rely on manual settings. Patients in the study will be monitored while receiving noninvasive ventilation (a way to help them breathe without needing a breathing tube), and their breathing patterns will be recorded to compare how well each method works.
To participate, individuals must be adults over 18 years old who are currently in the intensive care unit or emergency department and need help with breathing for at least two hours. They should be able to give consent or have a family member provide consent for them if they are unable to do so. Participants will have their breathing monitored using advanced technology that tracks their efforts in real-time, allowing researchers to gather important data on how effectively each method supports their breathing. It’s important to note that those who are very unstable or require specific medical attention may not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients older than 18 years of age
- • Hospitalized at the ICU or emergency department with the intention of treatment with Noninvasive ventilation at least for the upcoming 2 hours with spontaneous breathing activity
- • Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation
- Exclusion Criteria:
- • Formalized ethical decision to withhold or withdraw life support
- • Patient included in another interventional research study under consent
- • Patient already enrolled in the present study in a previous episode of respiratory failure
- • Pregnant woman
- • Patients deemed at high risk for the need of transportation from an intensive care unit or emergency department to another ward, diagnostic unit or any other hospital
- • Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h
- • Not being able to obtain reference waveforms due to technical or medical problems
- • Vulnerable population
- • Increase or decrease of ventilatory support either in pressures, fraction of inspired oxygen or mode of ventilation during study period
About Başakşehir çam & Sakura City Hospital
Başakşehir Çam & Sakura City Hospital is a leading healthcare institution in Turkey, renowned for its state-of-the-art facilities and commitment to patient-centered care. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation across various therapeutic areas. With a multidisciplinary team of experts and a focus on ethical practices, Başakşehir Çam & Sakura City Hospital actively collaborates with industry partners and academic institutions to facilitate cutting-edge clinical trials, aiming to improve treatment outcomes and enhance the overall quality of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Izmir, , Turkey
Patients applied
Trial Officials
Ramazan Guven, Associate professor
Principal Investigator
Basaksehir Cam Sakura city Hospital, Istanbul
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported